Westfield Capital Management CO LP Aclaris Therapeutics, Inc. Transaction History

Westfield Capital Management CO LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$14.38 - $20.89 $10.8 Million - $15.7 Million	-750,604 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$16.46 - $20.33 $662,268 - $817,977	40,235 Added 5.66%	750,604 $15 Million
Q1 2018 May 14, 2018	SELL	$17.08 - $25.64 $1.54 Million - $2.31 Million	-90,000 Reduced 11.24%	710,369 $12.4 Million
Q4 2017 Feb 13, 2018	SELL	$21.47 - $27.8 $6.26 Million - $8.11 Million	-291,575 Reduced 26.7%	800,369 $19.7 Million
Q3 2017 Nov 13, 2017	BUY	$23.02 - $28.8 $25.1 Million - $31.4 Million	1,091,944	1,091,944 $28.2 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.